Literature DB >> 4316706

[Effect of the liver on experimental renal hypertension due to intrarenal causes].

L Brunner, B Heisig, H Emmermann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4316706     DOI: 10.1007/bf01238575

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  44 in total

1.  IDENTIFICATION OF THE PRESSOR SUBSTANCE PRODUCED IN EXPERIMENTAL NEPHRITIS AND PREVENTION OF THE HYPERTENSION BY A SURGICAL PROCEDURE.

Authors:  K SAKAMOTO
Journal:  Kobe J Med Sci       Date:  1963-03

Review 2.  RENIN-ANGIOTENSIN SYSTEM, ALDOSTERONE, AND SODIUM BALANCE.

Authors:  F GROSS; H BRUNNER; M ZIEGLER
Journal:  Recent Prog Horm Res       Date:  1965

3.  The antihypertensive endocrine function of the kidney.

Authors:  T TOTH; J BARTFAI
Journal:  Clin Sci       Date:  1961-06       Impact factor: 6.124

4.  SUGGESTED CHANGE IN DESIGNATION OF "RENIN-ACTIVATOR" (HYPERTENSINOGEN) TO RENIN-SUBSTRATE (agr GLOBULIN).

Authors:  I H Page; O M Helmer; A A Plentl; K G Kohlstaedt; A C Corcoran
Journal:  Science       Date:  1943-08-13       Impact factor: 47.728

5.  The effect of portacaval transposition on the inactivation of angiotensin by the canine liver.

Authors:  D T Schwartz
Journal:  Ann Surg       Date:  1967-07       Impact factor: 12.969

6.  [Venous reno-portal anastomoses on dogs with Goldblatt kidneys].

Authors:  H Emmermann; L Brunner
Journal:  Langenbecks Arch Chir       Date:  1966

7.  The production of sustained hypertension in dogs by unilateral renal arterial injection of iron carbonyl particles.

Authors:  D T Schwartz; H A Zintel
Journal:  J Urol       Date:  1966-04       Impact factor: 7.450

8.  The effect of portacaval transposition on renal hypertension in the dog.

Authors:  D T Schwartz; R E McCabe; H A Zintel
Journal:  Surg Gynecol Obstet       Date:  1966-02

9.  [Surgical treatment of renovascular hypertension].

Authors:  F W Eigler
Journal:  Dtsch Med Wochenschr       Date:  1967-01-20       Impact factor: 0.628

10.  [Renin-angiotensin-aldosterone system in hypertensive conditions].

Authors:  P Weidmann; W Siegenthaler
Journal:  Dtsch Med Wochenschr       Date:  1967-10-27       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.